155 related articles for article (PubMed ID: 36621920)
1. Tumour-induced osteomalacia (TIO).
Molendowska A; Jakubowska J; Jędrzejuk D; Szymczak J
Endokrynol Pol; 2022; 73(5):903-904. PubMed ID: 36621920
[TBL] [Abstract][Full Text] [Related]
2. Challenging case of tumour-induced osteomalacia.
Kumar P; Jadhav DV; Ravat SH; Jain N
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
[TBL] [Abstract][Full Text] [Related]
3. Tumour-induced osteomalacia: a literature review and a case report.
Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
[TBL] [Abstract][Full Text] [Related]
5. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
6. Tumor induced osteomalacia.
Filipová L; Lazúrová I
Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
[TBL] [Abstract][Full Text] [Related]
9. Tumor induced osteomalacia from a peripheral mesenchymal tumour of the foot.
Strydom A; Greeff W; Ferrao PNF; Saragas NP
Foot (Edinb); 2023 May; 55():101979. PubMed ID: 36871520
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
11. Left maxillary sinus tumour-induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review.
Li B; Dong Y; Liu D; Yao Q; Guo S; Xin H; Wang H; Liu L; Zhang Y
Intern Med J; 2020 Jun; 50(6):755-761. PubMed ID: 32537923
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
[TBL] [Abstract][Full Text] [Related]
13. A case of hyperparathyroidism secondary to tumor-induced osteomalacia.
Yang Y; Jin P; Zhang S; Chen K; He H; Mo Z; Yuan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1937-1944. PubMed ID: 38448388
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer.
Abramson M; Glezerman IG; Srinivasan M; Ross R; Flombaum C; Gutgarts V
Clin Nephrol; 2021 Feb; 95(2):104-111. PubMed ID: 33191899
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.
Rendina D; Abate V; Cacace G; D'Elia L; De Filippo G; Del Vecchio S; Galletti F; Cuocolo A; Strazzullo P
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3428-e3436. PubMed ID: 35468192
[TBL] [Abstract][Full Text] [Related]
16. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia.
Schouten BJ; Doogue MP; Soule SG; Hunt PJ
Ann Clin Biochem; 2009 Mar; 46(Pt 2):167-9. PubMed ID: 19151167
[TBL] [Abstract][Full Text] [Related]
17. Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration.
Klein K; Asaad S; Econs M; Rubin JE
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29298794
[TBL] [Abstract][Full Text] [Related]
18. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced Osteomalacia in a Boy with Maxillary Ossifying Fibroma.
Thi HN; Manh CP; Tuan LT; Le Thi LA; Thanh NN; Vilaiyuk S
J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):421-425. PubMed ID: 35135186
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
[Next] [New Search]